Cidel Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Cidel Asset Management's REGN Position: Q2 2026 in Review
Cidel Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 7.8% in Q2 2026, buying an estimated $38.1K and bringing the position to 775 shares worth $483K. The position accounts for 0.02% of the portfolio, ranked #269.
Cidel Asset Management first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $556K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Cidel Asset Management held 775 shares of Regeneron Pharmaceuticals worth $483K as of Q2 2026.
- Cidel Asset Management bought 56 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $38.1K.
- Regeneron Pharmaceuticals made up 0.02% of Cidel Asset Management's portfolio in Q2 2026, its #269 holding.
- Cidel Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
- Cidel Asset Management's Regeneron Pharmaceuticals position peaked at $556K in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.